Ethan M. Shevach

发表

Mediate Tumor Rejection Cutting Edge: IL-10-Producing CD4+ T Cells

Benjamin M. Segal, Deborah D. Glass, Ethan M. Shevach, 2013 .

Constitutive Presentation of a Natural Tissue Autoantigen Exclusively by Dendritic Cells in the Draining Lymph Node

Ethan M. Shevach, Ronald N. Germain, R. Germain, 2002, The Journal of experimental medicine.

Cutting Edge: Depletion of CD4+CD25+ Regulatory T Cells Is Necessary, But Not Sufficient, for Induction of Organ-Specific Autoimmune Disease

Ethan M. Shevach, E. Shevach, Rebecca S. McHugh, 2002, The Journal of Immunology.

Engagement of Glucocorticoid-Induced TNFR Family-Related Receptor on Effector T Cells by its Ligand Mediates Resistance to Suppression by CD4+CD25+ T Cells

Ethan M. Shevach, Mary Collins, Beatriz M. Carreno, 2004, The Journal of Immunology.

Cutting Edge: IL-2 Is Critically Required for the In Vitro Activation of CD4+CD25+ T Cell Suppressor Function

Ethan M. Shevach, E. Shevach, C. Piccirillo, 2004, The Journal of Immunology.

CD4+CD25+ suppressor T cells: more questions than answers

Ethan M. Shevach, E. Shevach, 2002, Nature Reviews Immunology.

CD4+CD25+ Regulatory T Cells Can Mediate Suppressor Function in the Absence of Transforming Growth Factor β1 Production and Responsiveness

Ethan M. Shevach, E. Shevach, J. Letterio, 2002, The Journal of experimental medicine.

Suppressor Effector Function of CD4+CD25+ Immunoregulatory T Cells Is Antigen Nonspecific

Ethan M. Shevach, E. Shevach, Angela M. Thornton, 2000, The Journal of Immunology.

Highlights of 10 years of immunology in Nature Reviews Immunology

Chen Dong, Ethan M. Shevach, Siamon Gordon, 2011, Nature Reviews Immunology.

CD4+CD25+ Immunoregulatory T Cells Suppress Polyclonal T Cell Activation In Vitro by Inhibiting Interleukin 2 Production

Ethan M. Shevach, E. Shevach, Angela M. Thornton, 1998, The Journal of experimental medicine.